Neutrophil extracellular traps and cancer: trapping our attention with their involvement in ovarian cancer
M Castaño, S Tomás-Pérez, E González-Cantó… - International Journal of …, 2023 - mdpi.com
Neutrophils, the most abundant circulating leukocytes, play a well-known role in defense
against pathogens through phagocytosis and degranulation. However, a new mechanism …
against pathogens through phagocytosis and degranulation. However, a new mechanism …
Development of the peritoneal metastasis: a review of back-grounds, mechanisms, treatments and prospects
K Ren, X Xie, T Min, T Sun, H Wang, Y Zhang… - Journal of Clinical …, 2022 - mdpi.com
Peritoneal metastasis is a malignant disease which originated from several gastrointestinal
and gynecological carcinomas and has been leading to a suffering condition in patients for …
and gynecological carcinomas and has been leading to a suffering condition in patients for …
Prediction of surgical outcome in advanced ovarian cancer by imaging and laparoscopy: a narrative review
P Pinto, A Burgetova, D Cibula, IS Haldorsen… - Cancers, 2023 - mdpi.com
Simple Summary Maximal-effort debulking surgery is the recommended approach for
advanced-stage ovarian cancer. The role of imaging is to provide a preoperative systematic …
advanced-stage ovarian cancer. The role of imaging is to provide a preoperative systematic …
Validation of three predictive models for suboptimal cytoreductive surgery in advanced ovarian cancer
The standard treatment for advanced ovarian cancer (AOC) is cytoreduction surgery and
adjuvant chemotherapy. Tumor volume after surgery is a major prognostic factor for these …
adjuvant chemotherapy. Tumor volume after surgery is a major prognostic factor for these …
Optimal First-Line Medico-Surgical Strategy in Ovarian Cancers: Are We There Yet?
S Quesada, QD Thomas, PE Colombo, F Fiteni - Cancers, 2023 - mdpi.com
Simple Summary Cytoreductive surgery represents the cornerstone of the management of
advanced epithelial ovarian cancers (aEOC). Currently, two alternative strategies coexist …
advanced epithelial ovarian cancers (aEOC). Currently, two alternative strategies coexist …
Interplay between microRNAs and oxidative stress in ovarian conditions with a focus on ovarian cancer and endometriosis
J Marí-Alexandre, AP Carcelén, C Agababyan… - International Journal of …, 2019 - mdpi.com
Ovarian cancer and endometriosis are two distinct gynaecological conditions that share
many biological aspects incuding proliferation, invasion of surrounding tissue, inflammation …
many biological aspects incuding proliferation, invasion of surrounding tissue, inflammation …
Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in gynecologic malignancies
MT Climent, A Serra, J Gilabert-Estellés… - Journal of Clinical …, 2021 - mdpi.com
Objective: Peritoneal carcinomatosis is a disease's presentation in the advanced stages of
many gynecologic tumours. The distribution and volume of the disease are the main factors …
many gynecologic tumours. The distribution and volume of the disease are the main factors …
A new promising way of maintenance therapy in advanced ovarian cancer: a comparative clinical study
VI Kiselev, LA Ashrafyan, EL Muyzhnek, EV Gerfanova… - BMC cancer, 2018 - Springer
Background There is an urgent need for more novel and efficacious therapeutic agents and
strategies for the treatment of ovarian cancer-one of the most formidable female …
strategies for the treatment of ovarian cancer-one of the most formidable female …
Development of a novel intra-operative score to record diseases' anatomic fingerprints (ANAFI score) for the prediction of complete cytoreduction in advanced-stage …
A Laios, E Kalampokis, R Johnson, S Munot… - Cancers, 2023 - mdpi.com
Simple Summary The current scoring systems fail to reflect the patient's real anatomy, as
seen by the surgeon upon cytoreduction for advanced-stage epithelial ovarian cancer …
seen by the surgeon upon cytoreduction for advanced-stage epithelial ovarian cancer …
The pathologic peritoneal cancer index (PCI) strongly differs from the surgical PCI in peritoneal metastases arising from various primary tumors
A Bhatt, Y Yonemura, S Mehta, N Benzerdjeb… - Annals of Surgical …, 2020 - Springer
Background The surgical peritoneal cancer index (sPCI) is calculated based on a subjective
evaluation of the extent of peritoneal disease during surgery. The pathologic PCI (pPCI) may …
evaluation of the extent of peritoneal disease during surgery. The pathologic PCI (pPCI) may …